OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Construction of a lipid metabolism‐related and immune‐associated prognostic signature for hepatocellular carcinoma
Bo Hu, Xiaobo Yang, Xinting Sang
Cancer Medicine (2020) Vol. 9, Iss. 20, pp. 7646-7662
Open Access | Times Cited: 56
Bo Hu, Xiaobo Yang, Xinting Sang
Cancer Medicine (2020) Vol. 9, Iss. 20, pp. 7646-7662
Open Access | Times Cited: 56
Showing 26-50 of 56 citing articles:
Peroxisome-related genes in hepatocellular carcinoma correlated with tumor metabolism and overall survival
Tong Liu, Zhuhui Yuan, Hao Wang, et al.
Clinics and Research in Hepatology and Gastroenterology (2021) Vol. 46, Iss. 10, pp. 101835-101835
Closed Access | Times Cited: 8
Tong Liu, Zhuhui Yuan, Hao Wang, et al.
Clinics and Research in Hepatology and Gastroenterology (2021) Vol. 46, Iss. 10, pp. 101835-101835
Closed Access | Times Cited: 8
Bioinformatics Analysis and Structure of Gastric Cancer Prognosis Model Based on Lipid Metabolism and Immune Microenvironment
Yongzhi Chen, Yuan Hongjun, Qian Yu, et al.
Genes (2022) Vol. 13, Iss. 9, pp. 1581-1581
Open Access | Times Cited: 6
Yongzhi Chen, Yuan Hongjun, Qian Yu, et al.
Genes (2022) Vol. 13, Iss. 9, pp. 1581-1581
Open Access | Times Cited: 6
Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma
Ping Liu, Ziqing Zhu, Jiayao Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Ping Liu, Ziqing Zhu, Jiayao Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Diaoyi Tan, Daojia Miao, Chuanyi Zhao, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Development and validation of metabolic models for predicting survival and immune status of hepatocellular carcinoma patients
Xueying Li, Mengli Gu, Qiying Hu, et al.
Advances in Clinical and Experimental Medicine (2023) Vol. 32, Iss. 12, pp. 1423-1439
Open Access | Times Cited: 3
Xueying Li, Mengli Gu, Qiying Hu, et al.
Advances in Clinical and Experimental Medicine (2023) Vol. 32, Iss. 12, pp. 1423-1439
Open Access | Times Cited: 3
Characteristics of long‐chain acyl‐CoA synthetases in metabolism and cancer
Linlin Zhang, Xiangdong Wang
Clinical and Translational Discovery (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 3
Linlin Zhang, Xiangdong Wang
Clinical and Translational Discovery (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 3
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
Guohong Liu, Liping Wang, Lili Ji, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Guohong Liu, Liping Wang, Lili Ji, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Identification and immune landscape analysis of fatty acid metabolism genes related subtypes of gastric cancer
Rong Huang, Tailiang Lu, Rui Zhou
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Rong Huang, Tailiang Lu, Rui Zhou
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Identification of a nucleotide metabolism-related signature to predict prognosis and guide patient care in hepatocellular carcinoma
Yu Li, Chunyan Wu, Yingnan Ge, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 2
Yu Li, Chunyan Wu, Yingnan Ge, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 2
A novel fatty acid metabolism-related gene prognostic signature and candidate drugs for patients with hepatocellular carcinoma
H. J. Yang, Xin Yang, Jinlu Guo, et al.
PeerJ (2023) Vol. 11, pp. e14622-e14622
Open Access | Times Cited: 2
H. J. Yang, Xin Yang, Jinlu Guo, et al.
PeerJ (2023) Vol. 11, pp. e14622-e14622
Open Access | Times Cited: 2
Identification of three metabolic subtypes in gastric cancer and the construction of a metabolic pathway-based risk model that predicts the overall survival of GC patients
Tongzuan Chen, Liqian zhao, Junbo Chen, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
Tongzuan Chen, Liqian zhao, Junbo Chen, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
A novel fatty-acid metabolism-based classification for triple negative breast cancer
Xia Yang, Wen Tang, Yongtao He, et al.
Aging (2023)
Open Access | Times Cited: 2
Xia Yang, Wen Tang, Yongtao He, et al.
Aging (2023)
Open Access | Times Cited: 2
DNA replication stress stratifies prognosis and enables exploitable therapeutic vulnerabilities of HBV-associated hepatocellular carcinoma: An <i>in-silico</i> precision oncology strategy
Xiaofan Lu, Jialin Meng, Haitao Wang, et al.
The Innovation Medicine (2023) Vol. 1, Iss. 1, pp. 100014-100014
Open Access | Times Cited: 2
Xiaofan Lu, Jialin Meng, Haitao Wang, et al.
The Innovation Medicine (2023) Vol. 1, Iss. 1, pp. 100014-100014
Open Access | Times Cited: 2
Derivation and validation of a lipid-covered prognostic model for mature T-cell lymphomas
Tiange Lu, Lei Shi, Guanggang Shi, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Tiange Lu, Lei Shi, Guanggang Shi, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Metabolome and transcriptome integration reveals metabolic profile of hepatocellular carcinoma
Guojun Hou, Wenfang Xu, Dongyang Ding, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 12, pp. 2321-2330
Closed Access | Times Cited: 3
Guojun Hou, Wenfang Xu, Dongyang Ding, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 12, pp. 2321-2330
Closed Access | Times Cited: 3
A Four Amino Acid Metabolism-Associated Genes (AMGs) Signature for Predicting Overall Survival Outcomes and Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Lusheng Liao, Zijun Xiao, Junli Wang, et al.
Biochemical Genetics (2023) Vol. 62, Iss. 3, pp. 1577-1602
Closed Access | Times Cited: 1
Lusheng Liao, Zijun Xiao, Junli Wang, et al.
Biochemical Genetics (2023) Vol. 62, Iss. 3, pp. 1577-1602
Closed Access | Times Cited: 1
High expression of SMPD4 promotes liver cancer and is associated with poor prognosis
Wang Rongyue, Su Yanze, Lin Zhiheng, et al.
Research Square (Research Square) (2024)
Open Access
Wang Rongyue, Su Yanze, Lin Zhiheng, et al.
Research Square (Research Square) (2024)
Open Access
A Novel Amino Acid‐Related Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma
Shuyi Wang, Hong Huang, Xingwang Hu, et al.
Cancer Reports (2024) Vol. 7, Iss. 7
Open Access
Shuyi Wang, Hong Huang, Xingwang Hu, et al.
Cancer Reports (2024) Vol. 7, Iss. 7
Open Access
Identification of prognostic biomarkers for hepatocellular carcinoma with vascular invasion
Lei Sun, Fan Chen, Ping Xu, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 7, pp. 2828-2839
Open Access
Lei Sun, Fan Chen, Ping Xu, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 7, pp. 2828-2839
Open Access
Developing a Risk Model of Lipid Metabolism-associated Genes: Implications for Clinical Prognosis and Tumor Immune Microenvironment in Gastric Cancer
Yanan Xiao, Qin Yu, Zewen Zhu, et al.
Research Square (Research Square) (2024)
Open Access
Yanan Xiao, Qin Yu, Zewen Zhu, et al.
Research Square (Research Square) (2024)
Open Access
WITHDRAWN: Developing a Risk Model of Lipid Metabolism-associated Genes: Implications for Clinical Prognosis and Tumor Immune Microenvironment in Gastric Cancer
Yanan Xiao, Qin Yu, Zewen Zhu, et al.
Research Square (Research Square) (2024)
Open Access
Yanan Xiao, Qin Yu, Zewen Zhu, et al.
Research Square (Research Square) (2024)
Open Access
Screening for Lipid-Metabolism-Related Genes and Identifying the Diagnostic Potential of ANGPTL6 for HBV-Related Early-Stage Hepatocellular Carcinoma
Duo Zuo, Jiawei Xiao, Haohua An, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1700-1700
Open Access | Times Cited: 2
Duo Zuo, Jiawei Xiao, Haohua An, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1700-1700
Open Access | Times Cited: 2
[NDRG2 inhibits tumorigenesis of hepatocellular carcinoma by regulating metabolism of phospholipids and triglyceride: a metabonomic analysis].
J Wang, Yunfeng Yuan, K Zhang, et al.
PubMed (2022) Vol. 42, Iss. 12, pp. 1765-1773
Closed Access | Times Cited: 1
J Wang, Yunfeng Yuan, K Zhang, et al.
PubMed (2022) Vol. 42, Iss. 12, pp. 1765-1773
Closed Access | Times Cited: 1
Linc01018 / hsa-mir-182-5p / ADH4 Axis Study on the Role and Mechanism in the Occurrence and Development of Liver Cancer
Li-Ting Wang, Zhen‐Yu Chen, Xiaoling Wang, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Li-Ting Wang, Zhen‐Yu Chen, Xiaoling Wang, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Identification of two novel lipid metabolism-related long non-coding RNAs (SNHG17 and LINC00837) as potential signatures for osteosarcoma prognosis and precise treatment
Zhifang Tang, Hanzhen Feng, Longjun Shu, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access
Zhifang Tang, Hanzhen Feng, Longjun Shu, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access
